Mycoplasma pneumoniae co-infection with SARS-CoV-2: A case report.
Rama ChaudhryK SreenathE V VinayarajBiswajeet SahooM R Vishnu NarayananK V P Sai KiranPriyam BatraNisha RathorSheetal SinghAnant MohanSushma BhatnagarPublished in: Access microbiology (2021)
We report co-infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Mycoplasma pneumoniae in a patient with pneumonia in India. Atypical bacterial pathogens causing community-acquired pneumonia may share similar clinical presentations and radiographic features with SARS-CoV-2 making a thorough differential diagnosis essential. The co-infection of SARS-CoV-2 and M. pneumoniae is infrequently reported in the literature. Broader testing for common respiratory pathogens should be performed in severe COVID-19 cases to rule out other concurrent infections. Early identification of co-existing respiratory pathogens could provide pathogen-directed therapy, and can save patient lives during the ongoing COVID-19 outbreak.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- respiratory tract
- community acquired pneumonia
- gram negative
- case report
- coronavirus disease
- antimicrobial resistance
- systematic review
- stem cells
- early onset
- squamous cell carcinoma
- mesenchymal stem cells
- candida albicans
- bone marrow
- rectal cancer
- locally advanced
- respiratory failure